FR2166316A1 - 7-acylcephalosporins - prepd via a silylated inter - Google Patents

7-acylcephalosporins - prepd via a silylated inter

Info

Publication number
FR2166316A1
FR2166316A1 FR7200514A FR7200514A FR2166316A1 FR 2166316 A1 FR2166316 A1 FR 2166316A1 FR 7200514 A FR7200514 A FR 7200514A FR 7200514 A FR7200514 A FR 7200514A FR 2166316 A1 FR2166316 A1 FR 2166316A1
Authority
FR
France
Prior art keywords
alkyl
aryl
hal
prepd
inter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7200514A
Other languages
English (en)
French (fr)
Other versions
FR2166316B1 (enrdf_load_html_response
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to FR7200514A priority Critical patent/FR2166316A1/fr
Publication of FR2166316A1 publication Critical patent/FR2166316A1/fr
Application granted granted Critical
Publication of FR2166316B1 publication Critical patent/FR2166316B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D501/06—Acylation of 7-aminocephalosporanic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7200514A 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter Granted FR2166316A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7200514A FR2166316A1 (en) 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7200514A FR2166316A1 (en) 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter

Publications (2)

Publication Number Publication Date
FR2166316A1 true FR2166316A1 (en) 1973-08-17
FR2166316B1 FR2166316B1 (enrdf_load_html_response) 1977-10-28

Family

ID=9091611

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7200514A Granted FR2166316A1 (en) 1972-01-07 1972-01-07 7-acylcephalosporins - prepd via a silylated inter

Country Status (1)

Country Link
FR (1) FR2166316A1 (enrdf_load_html_response)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2349589A1 (fr) * 1976-04-27 1977-11-25 Bristol Myers Co Procede de preparation d'une cephalosporine et produit obtenu
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2349589A1 (fr) * 1976-04-27 1977-11-25 Bristol Myers Co Procede de preparation d'une cephalosporine et produit obtenu
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US6664420B2 (en) * 2000-08-09 2003-12-16 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US6855826B2 (en) * 2000-08-09 2005-02-15 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US7041829B2 (en) 2000-08-09 2006-05-09 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US7132537B2 (en) 2000-08-09 2006-11-07 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US7211667B2 (en) 2000-08-09 2007-05-01 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US7619097B2 (en) * 2000-08-09 2009-11-17 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US7795450B2 (en) 2000-08-09 2010-09-14 Magnesium Diagnostics, Inc. Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US7982048B2 (en) 2000-08-09 2011-07-19 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
US8129545B2 (en) 2000-08-09 2012-03-06 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

Also Published As

Publication number Publication date
FR2166316B1 (enrdf_load_html_response) 1977-10-28

Similar Documents

Publication Publication Date Title
ES8406429A1 (es) "un metodo de preparacion de nuevas sulfonamidas sustituidas" nota: se solicita como divisional de la patente de invencion n 516.504.
GB1046506A (en) Guanidine compounds and process for their manufacture
FR2166316A1 (en) 7-acylcephalosporins - prepd via a silylated inter
ES415744A1 (es) Procedimiento para la produccion de compuestos heterocicli-cos de la serie del tiofeno.
NL7117455A (en) 7-acylcephalosporins - prepd via a silylated inter
ES8301237A1 (es) Un procedimiento para la preparacion de un derivado 2-tiope-nem
SE7409812L (enrdf_load_html_response)
GB1351031A (en) Manufacture of tetramisole and analogues thereof and of intermediates therefor
ES8604601A1 (es) Procedimiento de preparar derivados de penicilina
GB1272865A (en) PREPARATION OF Delta<3>-THIAZOLINES
ES405994A1 (es) Un procedimiento para preparar compuestos de cefalosporina.
ES466815A1 (es) Procedimiento de preparacion de (2-tio)ureas disustituidas en las posiciones 1 y 3.
GB1354939A (en) Process for the manufacture of 1,1,2-triphenylalk-1-enes
GB1459999A (en) Penicillin and cephalosporin intermediates
GB1124460A (en) Benzene-sulphonyl-semicarbazides and benzene-sulphonyl-ureas
GB2023142A (en) Ureido Cephelosporins
GB1472127A (en) Phenyl-thiadiazolyl-thiourea
GB914525A (en) New n-substituted carbamic acid esters and a process for the production thereof
ES8800220A1 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
ES418694A1 (es) Procedimiento para la preparacion de tiazolinas-(3) susti- tuidas en posiciones 2 y 5.
ES427185A1 (es) Un metodo de preparacion de butiramidas de oxi-iminocarba- moilaficidas y butiratos de oxi-iminocarbamoilo.
GB1269697A (en) Preparation of cephalosporin compounds
ES396648A1 (es) Procedimiento para la obtencion de 1,2,4-oxadiazoles.
ES437842A1 (es) Procedimiento para la preparacion de cefalosporinas.
JPS5236684A (en) Process for preparation of novel penicillins and cephalosporins

Legal Events

Date Code Title Description
ST Notification of lapse